Attention is focusing on whether a treatment for hyperlipidemia, Rosuvastatin OD (Orally Disintegrated Tablet) will be released.

Rosuvastatin OD was approved in Japan in 2016, but has not yet been released in Korea.

According to industries on the 25th, BCWORLD Pharm recently applied for approval of Rosuvastatin OD to the MFDS.

AstraZeneca's Crestor is the original for Rosuvastatin. Generics have been released in Korea since 2009, and 941 cases are currently approved. However, there is no formulation of ODT that is melted with the tongue without water. In Japan, AstraZeneca and Shionogi were approved for Crestor OD in 2016. It is said to have been developed by Shionogi.